 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 606
H.P. 422 House of  Representatives, February 16, 2017
An Act  To Ensure Access  to All Prescription  Drugs  Containing  
Cannabidiol Approved by the Federal Food and  Drug 
Administration
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative AUSTIN of Gray.
Cosponsored by Representatives:  FECTEAU of  Biddeford, HANLEY of Pittston, KINNEY of 
Knox, PICKETT of  Dixfield, STEARNS  of Guilford, WARD of Dedham, WHITE  of 
Washburn.

 
 Page 1 - 128LR2080(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA ยง2430 -C is enacted to read:  2 
ยง2430 -C.  Federal approval of cannabidiol  3 
1.  Federal approval.  A prescription medication containing cannabidiol that is 4 
approved pursuant to 21 Uni ted States Code, Section 360bb and 21 United States Code, 5 
Section 355 or under a federal interim final rule issued pursuant to 21 United States Code, 6 
Section 811(j) must be available in this State with similar control or decontrol within 30 7 
days of publica tion in the Federal Register of the interim final rule or federal final rule.  8 
2.  Emergency.  Control or decontrol under this section in conformance with federal 9 
law or rule may be altered by the Legislature or by emergency rule adopted by the 10 
department t o address an immediate danger to public health, safety or welfare.  11 
3.  Scope.  This section may not otherwise restrict or affect access to marijuana 12 
authorized under this chapter.  13 
SUMMARY  14 
This bill states that a prescription medication containing cannabidi ol that is approved 15 
by federal law or rule must be available in this State within 30 days of approval or 16 
publication in the Federal Register.  17 
 
